BIOHOPE is a start-up biomedical company focused in the research and development of novel diagnostic tools, to personalize and optimize the clinical management of chronic inflammation in patients under treatment with immunosuppressive therapies
Biohope has developed Immunobiogram®, a disruptive blood-based in vitro diagnosis device for the design of a personalized immunosuppressant therapy to treat patients with chronic inflammatory diseases.